Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

2.515 +0.145 (+6.12%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,805
Open 2.320
Bid (Size) 2.400 (30)
Ask (Size) 2.730 (1)
Prev. Close 2.370
Today's Range 2.320 - 2.520
52wk Range 1.120 - 6.740
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients
Via Investor Brand Network
Heartbeam Inc. (NASDAQ: BEAT) Near the Top of Equities by Percentage Gain on 3/20
Via Investor Brand Network
Topics Credit Cards
Exposures Interest Rates

Performance

YTD
-45.33%
-45.33%
1 Month
-26.25%
-26.25%
3 Month
-45.44%
-45.44%
6 Month
+1.41%
+1.41%
1 Year
+31.68%
+31.68%

More News

Read More
HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q4, FY 2022 Financial Report, Corporate Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
Exposures Financial Intellectual Property Product Safety
Earnings Preview For HeartBeam
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Acquires LIVEMOR Assets
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
HeartBeam Announces Acquisition of LIVMOR Assets
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Makes Changes in Senior Leadership Roles
Via Investor Brand Network
Exposures Product Safety
HeartBeam Announces Senior Leadership Change
From HeartBeam, Inc.
Via Business Wire
Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives
Via Talk Markets
HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call
Via Investor Brand Network
HeartBeam to Host Fourth Quarter and Full Year 2022 Results Conference Call on Thursday March 16, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President
Via Investor Brand Network
HeartBeam Appoints Robert Eno as President
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Growing Patent Portfolio Poised to Have Disruptive Effect on Multibillion Markets
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.